Global Peripheral T-cell lymphoma Therapy Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Peripheral T-cell lymphoma Therapy Industry Forecast” looks at past sales and reviews total world Peripheral T-cell lymphoma Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Peripheral T-cell lymphoma Therapy sales for 2023 through 2029. With Peripheral T-cell lymphoma Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peripheral T-cell lymphoma Therapy industry.
This Insight Report provides a comprehensive analysis of the global Peripheral T-cell lymphoma Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peripheral T-cell lymphoma Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peripheral T-cell lymphoma Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peripheral T-cell lymphoma Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peripheral T-cell lymphoma Therapy.
The global Peripheral T-cell lymphoma Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Peripheral T-cell lymphoma Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Peripheral T-cell lymphoma Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Peripheral T-cell lymphoma Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Peripheral T-cell lymphoma Therapy players cover Antengene, Genor BioPharma Co., Ltd., Hospira (Pfizer Inc.), Dizal Pharma, Bristol-Myers Squibb Company, Sigma-Tau Pharmaceuticals, Inc., Pacira Pharmaceuticals, Inc., Spectrum Pharmaceuticals, Inc. and Celgene Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral T-cell lymphoma Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Peripheral T-cell lymphoma Therapy Industry Forecast” looks at past sales and reviews total world Peripheral T-cell lymphoma Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Peripheral T-cell lymphoma Therapy sales for 2023 through 2029. With Peripheral T-cell lymphoma Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peripheral T-cell lymphoma Therapy industry.
This Insight Report provides a comprehensive analysis of the global Peripheral T-cell lymphoma Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peripheral T-cell lymphoma Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peripheral T-cell lymphoma Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peripheral T-cell lymphoma Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peripheral T-cell lymphoma Therapy.
The global Peripheral T-cell lymphoma Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Peripheral T-cell lymphoma Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Peripheral T-cell lymphoma Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Peripheral T-cell lymphoma Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Peripheral T-cell lymphoma Therapy players cover Antengene, Genor BioPharma Co., Ltd., Hospira (Pfizer Inc.), Dizal Pharma, Bristol-Myers Squibb Company, Sigma-Tau Pharmaceuticals, Inc., Pacira Pharmaceuticals, Inc., Spectrum Pharmaceuticals, Inc. and Celgene Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral T-cell lymphoma Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Chidamide
- Selinexor
- Other
- Hospitals
- Clinics
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Antengene
- Genor BioPharma Co., Ltd.
- Hospira (Pfizer Inc.)
- Dizal Pharma
- Bristol-Myers Squibb Company
- Sigma-Tau Pharmaceuticals, Inc.
- Pacira Pharmaceuticals, Inc.
- Spectrum Pharmaceuticals, Inc.
- Celgene Corporation
- Eisai Co., Ltd.
- Leadiant Biosciences
- Merck
- Genmab AS
- HUYABIO International
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peripheral T-cell lymphoma Therapy Market Size 2018-2029
2.1.2 Peripheral T-cell lymphoma Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Peripheral T-cell lymphoma Therapy Segment by Type
2.2.1 Chidamide
2.2.2 Selinexor
2.2.3 Other
2.3 Peripheral T-cell lymphoma Therapy Market Size by Type
2.3.1 Peripheral T-cell lymphoma Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Peripheral T-cell lymphoma Therapy Market Size Market Share by Type (2018-2023)
2.4 Peripheral T-cell lymphoma Therapy Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Peripheral T-cell lymphoma Therapy Market Size by Application
2.5.1 Peripheral T-cell lymphoma Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Peripheral T-cell lymphoma Therapy Market Size Market Share by Application (2018-2023)
3 PERIPHERAL T-CELL LYMPHOMA THERAPY MARKET SIZE BY PLAYER
3.1 Peripheral T-cell lymphoma Therapy Market Size Market Share by Players
3.1.1 Global Peripheral T-cell lymphoma Therapy Revenue by Players (2018-2023)
3.1.2 Global Peripheral T-cell lymphoma Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Peripheral T-cell lymphoma Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PERIPHERAL T-CELL LYMPHOMA THERAPY BY REGIONS
4.1 Peripheral T-cell lymphoma Therapy Market Size by Regions (2018-2023)
4.2 Americas Peripheral T-cell lymphoma Therapy Market Size Growth (2018-2023)
4.3 APAC Peripheral T-cell lymphoma Therapy Market Size Growth (2018-2023)
4.4 Europe Peripheral T-cell lymphoma Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Peripheral T-cell lymphoma Therapy Market Size by Country (2018-2023)
5.2 Americas Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023)
5.3 Americas Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peripheral T-cell lymphoma Therapy Market Size by Region (2018-2023)
6.2 APAC Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023)
6.3 APAC Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Peripheral T-cell lymphoma Therapy by Country (2018-2023)
7.2 Europe Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023)
7.3 Europe Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peripheral T-cell lymphoma Therapy by Region (2018-2023)
8.2 Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PERIPHERAL T-CELL LYMPHOMA THERAPY MARKET FORECAST
10.1 Global Peripheral T-cell lymphoma Therapy Forecast by Regions (2024-2029)
10.1.1 Global Peripheral T-cell lymphoma Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Peripheral T-cell lymphoma Therapy Forecast
10.1.3 APAC Peripheral T-cell lymphoma Therapy Forecast
10.1.4 Europe Peripheral T-cell lymphoma Therapy Forecast
10.1.5 Middle East & Africa Peripheral T-cell lymphoma Therapy Forecast
10.2 Americas Peripheral T-cell lymphoma Therapy Forecast by Country (2024-2029)
10.2.1 United States Peripheral T-cell lymphoma Therapy Market Forecast
10.2.2 Canada Peripheral T-cell lymphoma Therapy Market Forecast
10.2.3 Mexico Peripheral T-cell lymphoma Therapy Market Forecast
10.2.4 Brazil Peripheral T-cell lymphoma Therapy Market Forecast
10.3 APAC Peripheral T-cell lymphoma Therapy Forecast by Region (2024-2029)
10.3.1 China Peripheral T-cell lymphoma Therapy Market Forecast
10.3.2 Japan Peripheral T-cell lymphoma Therapy Market Forecast
10.3.3 Korea Peripheral T-cell lymphoma Therapy Market Forecast
10.3.4 Southeast Asia Peripheral T-cell lymphoma Therapy Market Forecast
10.3.5 India Peripheral T-cell lymphoma Therapy Market Forecast
10.3.6 Australia Peripheral T-cell lymphoma Therapy Market Forecast
10.4 Europe Peripheral T-cell lymphoma Therapy Forecast by Country (2024-2029)
10.4.1 Germany Peripheral T-cell lymphoma Therapy Market Forecast
10.4.2 France Peripheral T-cell lymphoma Therapy Market Forecast
10.4.3 UK Peripheral T-cell lymphoma Therapy Market Forecast
10.4.4 Italy Peripheral T-cell lymphoma Therapy Market Forecast
10.4.5 Russia Peripheral T-cell lymphoma Therapy Market Forecast
10.5 Middle East & Africa Peripheral T-cell lymphoma Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Peripheral T-cell lymphoma Therapy Market Forecast
10.5.2 South Africa Peripheral T-cell lymphoma Therapy Market Forecast
10.5.3 Israel Peripheral T-cell lymphoma Therapy Market Forecast
10.5.4 Turkey Peripheral T-cell lymphoma Therapy Market Forecast
10.5.5 GCC Countries Peripheral T-cell lymphoma Therapy Market Forecast
10.6 Global Peripheral T-cell lymphoma Therapy Forecast by Type (2024-2029)
10.7 Global Peripheral T-cell lymphoma Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Antengene
11.1.1 Antengene Company Information
11.1.2 Antengene Peripheral T-cell lymphoma Therapy Product Offered
11.1.3 Antengene Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Antengene Main Business Overview
11.1.5 Antengene Latest Developments
11.2 Genor BioPharma Co., Ltd.
11.2.1 Genor BioPharma Co., Ltd. Company Information
11.2.2 Genor BioPharma Co., Ltd. Peripheral T-cell lymphoma Therapy Product Offered
11.2.3 Genor BioPharma Co., Ltd. Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Genor BioPharma Co., Ltd. Main Business Overview
11.2.5 Genor BioPharma Co., Ltd. Latest Developments
11.3 Hospira (Pfizer Inc.)
11.3.1 Hospira (Pfizer Inc.) Company Information
11.3.2 Hospira (Pfizer Inc.) Peripheral T-cell lymphoma Therapy Product Offered
11.3.3 Hospira (Pfizer Inc.) Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Hospira (Pfizer Inc.) Main Business Overview
11.3.5 Hospira (Pfizer Inc.) Latest Developments
11.4 Dizal Pharma
11.4.1 Dizal Pharma Company Information
11.4.2 Dizal Pharma Peripheral T-cell lymphoma Therapy Product Offered
11.4.3 Dizal Pharma Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Dizal Pharma Main Business Overview
11.4.5 Dizal Pharma Latest Developments
11.5 Bristol-Myers Squibb Company
11.5.1 Bristol-Myers Squibb Company Company Information
11.5.2 Bristol-Myers Squibb Company Peripheral T-cell lymphoma Therapy Product Offered
11.5.3 Bristol-Myers Squibb Company Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Bristol-Myers Squibb Company Main Business Overview
11.5.5 Bristol-Myers Squibb Company Latest Developments
11.6 Sigma-Tau Pharmaceuticals, Inc.
11.6.1 Sigma-Tau Pharmaceuticals, Inc. Company Information
11.6.2 Sigma-Tau Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Product Offered
11.6.3 Sigma-Tau Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Sigma-Tau Pharmaceuticals, Inc. Main Business Overview
11.6.5 Sigma-Tau Pharmaceuticals, Inc. Latest Developments
11.7 Pacira Pharmaceuticals, Inc.
11.7.1 Pacira Pharmaceuticals, Inc. Company Information
11.7.2 Pacira Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Product Offered
11.7.3 Pacira Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Pacira Pharmaceuticals, Inc. Main Business Overview
11.7.5 Pacira Pharmaceuticals, Inc. Latest Developments
11.8 Spectrum Pharmaceuticals, Inc.
11.8.1 Spectrum Pharmaceuticals, Inc. Company Information
11.8.2 Spectrum Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Product Offered
11.8.3 Spectrum Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Spectrum Pharmaceuticals, Inc. Main Business Overview
11.8.5 Spectrum Pharmaceuticals, Inc. Latest Developments
11.9 Celgene Corporation
11.9.1 Celgene Corporation Company Information
11.9.2 Celgene Corporation Peripheral T-cell lymphoma Therapy Product Offered
11.9.3 Celgene Corporation Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Celgene Corporation Main Business Overview
11.9.5 Celgene Corporation Latest Developments
11.10 Eisai Co., Ltd.
11.10.1 Eisai Co., Ltd. Company Information
11.10.2 Eisai Co., Ltd. Peripheral T-cell lymphoma Therapy Product Offered
11.10.3 Eisai Co., Ltd. Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Eisai Co., Ltd. Main Business Overview
11.10.5 Eisai Co., Ltd. Latest Developments
11.11 Leadiant Biosciences
11.11.1 Leadiant Biosciences Company Information
11.11.2 Leadiant Biosciences Peripheral T-cell lymphoma Therapy Product Offered
11.11.3 Leadiant Biosciences Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Leadiant Biosciences Main Business Overview
11.11.5 Leadiant Biosciences Latest Developments
11.12 Merck
11.12.1 Merck Company Information
11.12.2 Merck Peripheral T-cell lymphoma Therapy Product Offered
11.12.3 Merck Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Merck Main Business Overview
11.12.5 Merck Latest Developments
11.13 Genmab AS
11.13.1 Genmab AS Company Information
11.13.2 Genmab AS Peripheral T-cell lymphoma Therapy Product Offered
11.13.3 Genmab AS Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Genmab AS Main Business Overview
11.13.5 Genmab AS Latest Developments
11.14 HUYABIO International
11.14.1 HUYABIO International Company Information
11.14.2 HUYABIO International Peripheral T-cell lymphoma Therapy Product Offered
11.14.3 HUYABIO International Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 HUYABIO International Main Business Overview
11.14.5 HUYABIO International Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peripheral T-cell lymphoma Therapy Market Size 2018-2029
2.1.2 Peripheral T-cell lymphoma Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Peripheral T-cell lymphoma Therapy Segment by Type
2.2.1 Chidamide
2.2.2 Selinexor
2.2.3 Other
2.3 Peripheral T-cell lymphoma Therapy Market Size by Type
2.3.1 Peripheral T-cell lymphoma Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Peripheral T-cell lymphoma Therapy Market Size Market Share by Type (2018-2023)
2.4 Peripheral T-cell lymphoma Therapy Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Peripheral T-cell lymphoma Therapy Market Size by Application
2.5.1 Peripheral T-cell lymphoma Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Peripheral T-cell lymphoma Therapy Market Size Market Share by Application (2018-2023)
3 PERIPHERAL T-CELL LYMPHOMA THERAPY MARKET SIZE BY PLAYER
3.1 Peripheral T-cell lymphoma Therapy Market Size Market Share by Players
3.1.1 Global Peripheral T-cell lymphoma Therapy Revenue by Players (2018-2023)
3.1.2 Global Peripheral T-cell lymphoma Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Peripheral T-cell lymphoma Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PERIPHERAL T-CELL LYMPHOMA THERAPY BY REGIONS
4.1 Peripheral T-cell lymphoma Therapy Market Size by Regions (2018-2023)
4.2 Americas Peripheral T-cell lymphoma Therapy Market Size Growth (2018-2023)
4.3 APAC Peripheral T-cell lymphoma Therapy Market Size Growth (2018-2023)
4.4 Europe Peripheral T-cell lymphoma Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Peripheral T-cell lymphoma Therapy Market Size by Country (2018-2023)
5.2 Americas Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023)
5.3 Americas Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peripheral T-cell lymphoma Therapy Market Size by Region (2018-2023)
6.2 APAC Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023)
6.3 APAC Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Peripheral T-cell lymphoma Therapy by Country (2018-2023)
7.2 Europe Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023)
7.3 Europe Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peripheral T-cell lymphoma Therapy by Region (2018-2023)
8.2 Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PERIPHERAL T-CELL LYMPHOMA THERAPY MARKET FORECAST
10.1 Global Peripheral T-cell lymphoma Therapy Forecast by Regions (2024-2029)
10.1.1 Global Peripheral T-cell lymphoma Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Peripheral T-cell lymphoma Therapy Forecast
10.1.3 APAC Peripheral T-cell lymphoma Therapy Forecast
10.1.4 Europe Peripheral T-cell lymphoma Therapy Forecast
10.1.5 Middle East & Africa Peripheral T-cell lymphoma Therapy Forecast
10.2 Americas Peripheral T-cell lymphoma Therapy Forecast by Country (2024-2029)
10.2.1 United States Peripheral T-cell lymphoma Therapy Market Forecast
10.2.2 Canada Peripheral T-cell lymphoma Therapy Market Forecast
10.2.3 Mexico Peripheral T-cell lymphoma Therapy Market Forecast
10.2.4 Brazil Peripheral T-cell lymphoma Therapy Market Forecast
10.3 APAC Peripheral T-cell lymphoma Therapy Forecast by Region (2024-2029)
10.3.1 China Peripheral T-cell lymphoma Therapy Market Forecast
10.3.2 Japan Peripheral T-cell lymphoma Therapy Market Forecast
10.3.3 Korea Peripheral T-cell lymphoma Therapy Market Forecast
10.3.4 Southeast Asia Peripheral T-cell lymphoma Therapy Market Forecast
10.3.5 India Peripheral T-cell lymphoma Therapy Market Forecast
10.3.6 Australia Peripheral T-cell lymphoma Therapy Market Forecast
10.4 Europe Peripheral T-cell lymphoma Therapy Forecast by Country (2024-2029)
10.4.1 Germany Peripheral T-cell lymphoma Therapy Market Forecast
10.4.2 France Peripheral T-cell lymphoma Therapy Market Forecast
10.4.3 UK Peripheral T-cell lymphoma Therapy Market Forecast
10.4.4 Italy Peripheral T-cell lymphoma Therapy Market Forecast
10.4.5 Russia Peripheral T-cell lymphoma Therapy Market Forecast
10.5 Middle East & Africa Peripheral T-cell lymphoma Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Peripheral T-cell lymphoma Therapy Market Forecast
10.5.2 South Africa Peripheral T-cell lymphoma Therapy Market Forecast
10.5.3 Israel Peripheral T-cell lymphoma Therapy Market Forecast
10.5.4 Turkey Peripheral T-cell lymphoma Therapy Market Forecast
10.5.5 GCC Countries Peripheral T-cell lymphoma Therapy Market Forecast
10.6 Global Peripheral T-cell lymphoma Therapy Forecast by Type (2024-2029)
10.7 Global Peripheral T-cell lymphoma Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Antengene
11.1.1 Antengene Company Information
11.1.2 Antengene Peripheral T-cell lymphoma Therapy Product Offered
11.1.3 Antengene Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Antengene Main Business Overview
11.1.5 Antengene Latest Developments
11.2 Genor BioPharma Co., Ltd.
11.2.1 Genor BioPharma Co., Ltd. Company Information
11.2.2 Genor BioPharma Co., Ltd. Peripheral T-cell lymphoma Therapy Product Offered
11.2.3 Genor BioPharma Co., Ltd. Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Genor BioPharma Co., Ltd. Main Business Overview
11.2.5 Genor BioPharma Co., Ltd. Latest Developments
11.3 Hospira (Pfizer Inc.)
11.3.1 Hospira (Pfizer Inc.) Company Information
11.3.2 Hospira (Pfizer Inc.) Peripheral T-cell lymphoma Therapy Product Offered
11.3.3 Hospira (Pfizer Inc.) Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Hospira (Pfizer Inc.) Main Business Overview
11.3.5 Hospira (Pfizer Inc.) Latest Developments
11.4 Dizal Pharma
11.4.1 Dizal Pharma Company Information
11.4.2 Dizal Pharma Peripheral T-cell lymphoma Therapy Product Offered
11.4.3 Dizal Pharma Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Dizal Pharma Main Business Overview
11.4.5 Dizal Pharma Latest Developments
11.5 Bristol-Myers Squibb Company
11.5.1 Bristol-Myers Squibb Company Company Information
11.5.2 Bristol-Myers Squibb Company Peripheral T-cell lymphoma Therapy Product Offered
11.5.3 Bristol-Myers Squibb Company Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Bristol-Myers Squibb Company Main Business Overview
11.5.5 Bristol-Myers Squibb Company Latest Developments
11.6 Sigma-Tau Pharmaceuticals, Inc.
11.6.1 Sigma-Tau Pharmaceuticals, Inc. Company Information
11.6.2 Sigma-Tau Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Product Offered
11.6.3 Sigma-Tau Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Sigma-Tau Pharmaceuticals, Inc. Main Business Overview
11.6.5 Sigma-Tau Pharmaceuticals, Inc. Latest Developments
11.7 Pacira Pharmaceuticals, Inc.
11.7.1 Pacira Pharmaceuticals, Inc. Company Information
11.7.2 Pacira Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Product Offered
11.7.3 Pacira Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Pacira Pharmaceuticals, Inc. Main Business Overview
11.7.5 Pacira Pharmaceuticals, Inc. Latest Developments
11.8 Spectrum Pharmaceuticals, Inc.
11.8.1 Spectrum Pharmaceuticals, Inc. Company Information
11.8.2 Spectrum Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Product Offered
11.8.3 Spectrum Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Spectrum Pharmaceuticals, Inc. Main Business Overview
11.8.5 Spectrum Pharmaceuticals, Inc. Latest Developments
11.9 Celgene Corporation
11.9.1 Celgene Corporation Company Information
11.9.2 Celgene Corporation Peripheral T-cell lymphoma Therapy Product Offered
11.9.3 Celgene Corporation Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Celgene Corporation Main Business Overview
11.9.5 Celgene Corporation Latest Developments
11.10 Eisai Co., Ltd.
11.10.1 Eisai Co., Ltd. Company Information
11.10.2 Eisai Co., Ltd. Peripheral T-cell lymphoma Therapy Product Offered
11.10.3 Eisai Co., Ltd. Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Eisai Co., Ltd. Main Business Overview
11.10.5 Eisai Co., Ltd. Latest Developments
11.11 Leadiant Biosciences
11.11.1 Leadiant Biosciences Company Information
11.11.2 Leadiant Biosciences Peripheral T-cell lymphoma Therapy Product Offered
11.11.3 Leadiant Biosciences Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Leadiant Biosciences Main Business Overview
11.11.5 Leadiant Biosciences Latest Developments
11.12 Merck
11.12.1 Merck Company Information
11.12.2 Merck Peripheral T-cell lymphoma Therapy Product Offered
11.12.3 Merck Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Merck Main Business Overview
11.12.5 Merck Latest Developments
11.13 Genmab AS
11.13.1 Genmab AS Company Information
11.13.2 Genmab AS Peripheral T-cell lymphoma Therapy Product Offered
11.13.3 Genmab AS Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Genmab AS Main Business Overview
11.13.5 Genmab AS Latest Developments
11.14 HUYABIO International
11.14.1 HUYABIO International Company Information
11.14.2 HUYABIO International Peripheral T-cell lymphoma Therapy Product Offered
11.14.3 HUYABIO International Peripheral T-cell lymphoma Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 HUYABIO International Main Business Overview
11.14.5 HUYABIO International Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Peripheral T-cell lymphoma Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Chidamide
Table 3. Major Players of Selinexor
Table 4. Major Players of Other
Table 5. Peripheral T-cell lymphoma Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Peripheral T-cell lymphoma Therapy Market Size Market Share by Type (2018-2023)
Table 8. Peripheral T-cell lymphoma Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Peripheral T-cell lymphoma Therapy Market Size Market Share by Application (2018-2023)
Table 11. Global Peripheral T-cell lymphoma Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Peripheral T-cell lymphoma Therapy Revenue Market Share by Player (2018-2023)
Table 13. Peripheral T-cell lymphoma Therapy Key Players Head office and Products Offered
Table 14. Peripheral T-cell lymphoma Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Peripheral T-cell lymphoma Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Peripheral T-cell lymphoma Therapy Market Size Market Share by Regions (2018-2023)
Table 19. Global Peripheral T-cell lymphoma Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Peripheral T-cell lymphoma Therapy Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Peripheral T-cell lymphoma Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Peripheral T-cell lymphoma Therapy Market Size Market Share by Country (2018-2023)
Table 23. Americas Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Peripheral T-cell lymphoma Therapy Market Size Market Share by Type (2018-2023)
Table 25. Americas Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Peripheral T-cell lymphoma Therapy Market Size Market Share by Application (2018-2023)
Table 27. APAC Peripheral T-cell lymphoma Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Peripheral T-cell lymphoma Therapy Market Size Market Share by Region (2018-2023)
Table 29. APAC Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Peripheral T-cell lymphoma Therapy Market Size Market Share by Type (2018-2023)
Table 31. APAC Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Peripheral T-cell lymphoma Therapy Market Size Market Share by Application (2018-2023)
Table 33. Europe Peripheral T-cell lymphoma Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Peripheral T-cell lymphoma Therapy Market Size Market Share by Country (2018-2023)
Table 35. Europe Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Peripheral T-cell lymphoma Therapy Market Size Market Share by Type (2018-2023)
Table 37. Europe Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Peripheral T-cell lymphoma Therapy Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Peripheral T-cell lymphoma Therapy
Table 46. Key Market Challenges & Risks of Peripheral T-cell lymphoma Therapy
Table 47. Key Industry Trends of Peripheral T-cell lymphoma Therapy
Table 48. Global Peripheral T-cell lymphoma Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Peripheral T-cell lymphoma Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Peripheral T-cell lymphoma Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Peripheral T-cell lymphoma Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Antengene Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 53. Antengene Peripheral T-cell lymphoma Therapy Product Offered
Table 54. Antengene Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Antengene Main Business
Table 56. Antengene Latest Developments
Table 57. Genor BioPharma Co., Ltd. Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 58. Genor BioPharma Co., Ltd. Peripheral T-cell lymphoma Therapy Product Offered
Table 59. Genor BioPharma Co., Ltd. Main Business
Table 60. Genor BioPharma Co., Ltd. Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Genor BioPharma Co., Ltd. Latest Developments
Table 62. Hospira (Pfizer Inc.) Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 63. Hospira (Pfizer Inc.) Peripheral T-cell lymphoma Therapy Product Offered
Table 64. Hospira (Pfizer Inc.) Main Business
Table 65. Hospira (Pfizer Inc.) Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Hospira (Pfizer Inc.) Latest Developments
Table 67. Dizal Pharma Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 68. Dizal Pharma Peripheral T-cell lymphoma Therapy Product Offered
Table 69. Dizal Pharma Main Business
Table 70. Dizal Pharma Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Dizal Pharma Latest Developments
Table 72. Bristol-Myers Squibb Company Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 73. Bristol-Myers Squibb Company Peripheral T-cell lymphoma Therapy Product Offered
Table 74. Bristol-Myers Squibb Company Main Business
Table 75. Bristol-Myers Squibb Company Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Bristol-Myers Squibb Company Latest Developments
Table 77. Sigma-Tau Pharmaceuticals, Inc. Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 78. Sigma-Tau Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Product Offered
Table 79. Sigma-Tau Pharmaceuticals, Inc. Main Business
Table 80. Sigma-Tau Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Sigma-Tau Pharmaceuticals, Inc. Latest Developments
Table 82. Pacira Pharmaceuticals, Inc. Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 83. Pacira Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Product Offered
Table 84. Pacira Pharmaceuticals, Inc. Main Business
Table 85. Pacira Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Pacira Pharmaceuticals, Inc. Latest Developments
Table 87. Spectrum Pharmaceuticals, Inc. Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 88. Spectrum Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Product Offered
Table 89. Spectrum Pharmaceuticals, Inc. Main Business
Table 90. Spectrum Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Spectrum Pharmaceuticals, Inc. Latest Developments
Table 92. Celgene Corporation Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 93. Celgene Corporation Peripheral T-cell lymphoma Therapy Product Offered
Table 94. Celgene Corporation Main Business
Table 95. Celgene Corporation Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Celgene Corporation Latest Developments
Table 97. Eisai Co., Ltd. Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 98. Eisai Co., Ltd. Peripheral T-cell lymphoma Therapy Product Offered
Table 99. Eisai Co., Ltd. Main Business
Table 100. Eisai Co., Ltd. Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Eisai Co., Ltd. Latest Developments
Table 102. Leadiant Biosciences Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 103. Leadiant Biosciences Peripheral T-cell lymphoma Therapy Product Offered
Table 104. Leadiant Biosciences Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Leadiant Biosciences Main Business
Table 106. Leadiant Biosciences Latest Developments
Table 107. Merck Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 108. Merck Peripheral T-cell lymphoma Therapy Product Offered
Table 109. Merck Main Business
Table 110. Merck Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Merck Latest Developments
Table 112. Genmab AS Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 113. Genmab AS Peripheral T-cell lymphoma Therapy Product Offered
Table 114. Genmab AS Main Business
Table 115. Genmab AS Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Genmab AS Latest Developments
Table 117. HUYABIO International Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 118. HUYABIO International Peripheral T-cell lymphoma Therapy Product Offered
Table 119. HUYABIO International Main Business
Table 120. HUYABIO International Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. HUYABIO International Latest Developments
Table 1. Peripheral T-cell lymphoma Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Chidamide
Table 3. Major Players of Selinexor
Table 4. Major Players of Other
Table 5. Peripheral T-cell lymphoma Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Peripheral T-cell lymphoma Therapy Market Size Market Share by Type (2018-2023)
Table 8. Peripheral T-cell lymphoma Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Peripheral T-cell lymphoma Therapy Market Size Market Share by Application (2018-2023)
Table 11. Global Peripheral T-cell lymphoma Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Peripheral T-cell lymphoma Therapy Revenue Market Share by Player (2018-2023)
Table 13. Peripheral T-cell lymphoma Therapy Key Players Head office and Products Offered
Table 14. Peripheral T-cell lymphoma Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Peripheral T-cell lymphoma Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Peripheral T-cell lymphoma Therapy Market Size Market Share by Regions (2018-2023)
Table 19. Global Peripheral T-cell lymphoma Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Peripheral T-cell lymphoma Therapy Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Peripheral T-cell lymphoma Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Peripheral T-cell lymphoma Therapy Market Size Market Share by Country (2018-2023)
Table 23. Americas Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Peripheral T-cell lymphoma Therapy Market Size Market Share by Type (2018-2023)
Table 25. Americas Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Peripheral T-cell lymphoma Therapy Market Size Market Share by Application (2018-2023)
Table 27. APAC Peripheral T-cell lymphoma Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Peripheral T-cell lymphoma Therapy Market Size Market Share by Region (2018-2023)
Table 29. APAC Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Peripheral T-cell lymphoma Therapy Market Size Market Share by Type (2018-2023)
Table 31. APAC Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Peripheral T-cell lymphoma Therapy Market Size Market Share by Application (2018-2023)
Table 33. Europe Peripheral T-cell lymphoma Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Peripheral T-cell lymphoma Therapy Market Size Market Share by Country (2018-2023)
Table 35. Europe Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Peripheral T-cell lymphoma Therapy Market Size Market Share by Type (2018-2023)
Table 37. Europe Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Peripheral T-cell lymphoma Therapy Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Peripheral T-cell lymphoma Therapy
Table 46. Key Market Challenges & Risks of Peripheral T-cell lymphoma Therapy
Table 47. Key Industry Trends of Peripheral T-cell lymphoma Therapy
Table 48. Global Peripheral T-cell lymphoma Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Peripheral T-cell lymphoma Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Peripheral T-cell lymphoma Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Peripheral T-cell lymphoma Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Antengene Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 53. Antengene Peripheral T-cell lymphoma Therapy Product Offered
Table 54. Antengene Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Antengene Main Business
Table 56. Antengene Latest Developments
Table 57. Genor BioPharma Co., Ltd. Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 58. Genor BioPharma Co., Ltd. Peripheral T-cell lymphoma Therapy Product Offered
Table 59. Genor BioPharma Co., Ltd. Main Business
Table 60. Genor BioPharma Co., Ltd. Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Genor BioPharma Co., Ltd. Latest Developments
Table 62. Hospira (Pfizer Inc.) Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 63. Hospira (Pfizer Inc.) Peripheral T-cell lymphoma Therapy Product Offered
Table 64. Hospira (Pfizer Inc.) Main Business
Table 65. Hospira (Pfizer Inc.) Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Hospira (Pfizer Inc.) Latest Developments
Table 67. Dizal Pharma Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 68. Dizal Pharma Peripheral T-cell lymphoma Therapy Product Offered
Table 69. Dizal Pharma Main Business
Table 70. Dizal Pharma Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Dizal Pharma Latest Developments
Table 72. Bristol-Myers Squibb Company Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 73. Bristol-Myers Squibb Company Peripheral T-cell lymphoma Therapy Product Offered
Table 74. Bristol-Myers Squibb Company Main Business
Table 75. Bristol-Myers Squibb Company Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Bristol-Myers Squibb Company Latest Developments
Table 77. Sigma-Tau Pharmaceuticals, Inc. Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 78. Sigma-Tau Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Product Offered
Table 79. Sigma-Tau Pharmaceuticals, Inc. Main Business
Table 80. Sigma-Tau Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Sigma-Tau Pharmaceuticals, Inc. Latest Developments
Table 82. Pacira Pharmaceuticals, Inc. Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 83. Pacira Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Product Offered
Table 84. Pacira Pharmaceuticals, Inc. Main Business
Table 85. Pacira Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Pacira Pharmaceuticals, Inc. Latest Developments
Table 87. Spectrum Pharmaceuticals, Inc. Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 88. Spectrum Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Product Offered
Table 89. Spectrum Pharmaceuticals, Inc. Main Business
Table 90. Spectrum Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Spectrum Pharmaceuticals, Inc. Latest Developments
Table 92. Celgene Corporation Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 93. Celgene Corporation Peripheral T-cell lymphoma Therapy Product Offered
Table 94. Celgene Corporation Main Business
Table 95. Celgene Corporation Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Celgene Corporation Latest Developments
Table 97. Eisai Co., Ltd. Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 98. Eisai Co., Ltd. Peripheral T-cell lymphoma Therapy Product Offered
Table 99. Eisai Co., Ltd. Main Business
Table 100. Eisai Co., Ltd. Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Eisai Co., Ltd. Latest Developments
Table 102. Leadiant Biosciences Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 103. Leadiant Biosciences Peripheral T-cell lymphoma Therapy Product Offered
Table 104. Leadiant Biosciences Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Leadiant Biosciences Main Business
Table 106. Leadiant Biosciences Latest Developments
Table 107. Merck Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 108. Merck Peripheral T-cell lymphoma Therapy Product Offered
Table 109. Merck Main Business
Table 110. Merck Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Merck Latest Developments
Table 112. Genmab AS Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 113. Genmab AS Peripheral T-cell lymphoma Therapy Product Offered
Table 114. Genmab AS Main Business
Table 115. Genmab AS Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Genmab AS Latest Developments
Table 117. HUYABIO International Details, Company Type, Peripheral T-cell lymphoma Therapy Area Served and Its Competitors
Table 118. HUYABIO International Peripheral T-cell lymphoma Therapy Product Offered
Table 119. HUYABIO International Main Business
Table 120. HUYABIO International Peripheral T-cell lymphoma Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. HUYABIO International Latest Developments
LIST OF FIGURES
Figure 1. Peripheral T-cell lymphoma Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peripheral T-cell lymphoma Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Peripheral T-cell lymphoma Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Peripheral T-cell lymphoma Therapy Sales Market Share by Country/Region (2022)
Figure 8. Peripheral T-cell lymphoma Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Peripheral T-cell lymphoma Therapy Market Size Market Share by Type in 2022
Figure 10. Peripheral T-cell lymphoma Therapy in Hospitals
Figure 11. Global Peripheral T-cell lymphoma Therapy Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Peripheral T-cell lymphoma Therapy in Clinics
Figure 13. Global Peripheral T-cell lymphoma Therapy Market: Clinics (2018-2023) & ($ Millions)
Figure 14. Global Peripheral T-cell lymphoma Therapy Market Size Market Share by Application in 2022
Figure 15. Global Peripheral T-cell lymphoma Therapy Revenue Market Share by Player in 2022
Figure 16. Global Peripheral T-cell lymphoma Therapy Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Peripheral T-cell lymphoma Therapy Market Size 2018-2023 ($ Millions)
Figure 18. APAC Peripheral T-cell lymphoma Therapy Market Size 2018-2023 ($ Millions)
Figure 19. Europe Peripheral T-cell lymphoma Therapy Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Americas Peripheral T-cell lymphoma Therapy Value Market Share by Country in 2022
Figure 22. United States Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Peripheral T-cell lymphoma Therapy Market Size Market Share by Region in 2022
Figure 27. APAC Peripheral T-cell lymphoma Therapy Market Size Market Share by Type in 2022
Figure 28. APAC Peripheral T-cell lymphoma Therapy Market Size Market Share by Application in 2022
Figure 29. China Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Peripheral T-cell lymphoma Therapy Market Size Market Share by Country in 2022
Figure 36. Europe Peripheral T-cell lymphoma Therapy Market Size Market Share by Type (2018-2023)
Figure 37. Europe Peripheral T-cell lymphoma Therapy Market Size Market Share by Application (2018-2023)
Figure 38. Germany Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 52. APAC Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 53. Europe Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 55. United States Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Canada Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 59. China Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Japan Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 61. Korea Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 63. India Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Australia Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 65. Germany Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 66. France Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 67. UK Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Italy Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 69. Russia Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Spain Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Israel Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Global Peripheral T-cell lymphoma Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Peripheral T-cell lymphoma Therapy Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Peripheral T-cell lymphoma Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peripheral T-cell lymphoma Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Peripheral T-cell lymphoma Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Peripheral T-cell lymphoma Therapy Sales Market Share by Country/Region (2022)
Figure 8. Peripheral T-cell lymphoma Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Peripheral T-cell lymphoma Therapy Market Size Market Share by Type in 2022
Figure 10. Peripheral T-cell lymphoma Therapy in Hospitals
Figure 11. Global Peripheral T-cell lymphoma Therapy Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Peripheral T-cell lymphoma Therapy in Clinics
Figure 13. Global Peripheral T-cell lymphoma Therapy Market: Clinics (2018-2023) & ($ Millions)
Figure 14. Global Peripheral T-cell lymphoma Therapy Market Size Market Share by Application in 2022
Figure 15. Global Peripheral T-cell lymphoma Therapy Revenue Market Share by Player in 2022
Figure 16. Global Peripheral T-cell lymphoma Therapy Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Peripheral T-cell lymphoma Therapy Market Size 2018-2023 ($ Millions)
Figure 18. APAC Peripheral T-cell lymphoma Therapy Market Size 2018-2023 ($ Millions)
Figure 19. Europe Peripheral T-cell lymphoma Therapy Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Americas Peripheral T-cell lymphoma Therapy Value Market Share by Country in 2022
Figure 22. United States Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Peripheral T-cell lymphoma Therapy Market Size Market Share by Region in 2022
Figure 27. APAC Peripheral T-cell lymphoma Therapy Market Size Market Share by Type in 2022
Figure 28. APAC Peripheral T-cell lymphoma Therapy Market Size Market Share by Application in 2022
Figure 29. China Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Peripheral T-cell lymphoma Therapy Market Size Market Share by Country in 2022
Figure 36. Europe Peripheral T-cell lymphoma Therapy Market Size Market Share by Type (2018-2023)
Figure 37. Europe Peripheral T-cell lymphoma Therapy Market Size Market Share by Application (2018-2023)
Figure 38. Germany Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Peripheral T-cell lymphoma Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 52. APAC Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 53. Europe Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 55. United States Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Canada Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 59. China Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Japan Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 61. Korea Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 63. India Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Australia Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 65. Germany Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 66. France Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 67. UK Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Italy Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 69. Russia Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Spain Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Israel Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Peripheral T-cell lymphoma Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Global Peripheral T-cell lymphoma Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Peripheral T-cell lymphoma Therapy Market Size Market Share Forecast by Application (2024-2029)
